mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.1 |
mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.1 |
mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.1 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.1 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.081 |
0.2 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |